General discussion, page-978

ARDS is the first of four independent trials, each of which has an addressable market of at least $1 billion. GW Pharma is evidence that the science of CBD is real, both medically and economically.

Even without the additional patient load of COVID, Sepsis Associated Adult Respiratory Distress Syndrome impacts 78.9 per 100,000 people each year in the USA alone of which the mortality rate is 37.5%.

This is a significant issue with no effective pharmaceutical treatments and a material economic burden.

Obstructive Sleep Apnoea (OSA) and Traumatic Brain Injury (TBI) are even greater opportunities IMO.

DYOR.